ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

ID Of Prognostic Factors In Mycosis Fungoides/Sezary Syndrome — Stella

Recruiting

Back to Mycosis Fungoides trials

Trial locations(13 sites)

United States

City of Hope, Duarte, California

Stanford University, School of Medicine, Palo Alto, California

University of Iowa, Iowa City, Iowa

Hackensack University Medical Center, Hackensack, New Jersey

University of Pittsburg, Pittsburgh, Pennsylvania

Key details

Sponsor

Stanford University

Enrollment target

~2,000 participants

Started

October 2016

Primary completion

March 2027

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov